skip to main content
Resultados 1 2 3 4 5 next page
Mostrar Somente
Result Number Material Type Add to My Shelf Action Record Details and Options
1
A promising therapy for fatty liver disease: PCSK9 inhibitors
Material Type:
Artigo
Adicionar ao Meu Espaço

A promising therapy for fatty liver disease: PCSK9 inhibitors

Han, Lizhu ; Wu, Liuyun ; Yin, Qinan ; Li, Lian ; Zheng, Xingyue ; Du, Shan ; Huang, Xuefei ; Bai, Lan ; Wang, Yi ; Bian, Yuan

Phytomedicine (Stuttgart), 2024-06, Vol.128, p.155505-155505, Article 155505 [Periódico revisado por pares]

Germany: Elsevier GmbH

Texto completo disponível

2
Effectiveness of 1-year pemafibrate treatment on steatotic liver disease: the influence of alcohol consumption
Material Type:
Artigo
Adicionar ao Meu Espaço

Effectiveness of 1-year pemafibrate treatment on steatotic liver disease: the influence of alcohol consumption

Iwasa, Motoh ; Sugimoto, Ryosuke ; Eguchi, Akiko ; Tamai, Yasuyuki ; Shigefuku, Ryuta ; Fujiwara, Naoto ; Tanaka, Hideaki ; Kobayashi, Yoshinao ; Ikoma, Jiro ; Kaito, Masahiko ; Nakagawa, Hayato

European journal of gastroenterology & hepatology, 2024-06, Vol.36 (6), p.793-801 [Periódico revisado por pares]

England

Texto completo disponível

3
Mitochondrial Adaptation in Nonalcoholic Fatty Liver Disease: Novel Mechanisms and Treatment Strategies
Material Type:
Artigo
Adicionar ao Meu Espaço

Mitochondrial Adaptation in Nonalcoholic Fatty Liver Disease: Novel Mechanisms and Treatment Strategies

Sunny, Nishanth E ; Bril, Fernando ; Cusi, Kenneth

Trends in endocrinology and metabolism, 2017-04, Vol.28 (4), p.250-260 [Periódico revisado por pares]

United States: Elsevier Ltd

Texto completo disponível

4
Neutralization of Oxidized Phospholipids Ameliorates Non-alcoholic Steatohepatitis
Material Type:
Artigo
Adicionar ao Meu Espaço

Neutralization of Oxidized Phospholipids Ameliorates Non-alcoholic Steatohepatitis

Sun, Xiaoli ; Seidman, Jason S. ; Zhao, Peng ; Troutman, Ty D. ; Spann, Nathanael J. ; Que, Xuchu ; Zhou, Fangli ; Liao, Zhongji ; Pasillas, Martina ; Yang, Xiaohong ; Magida, Jason A. ; Kisseleva, Tatiana ; Brenner, David A. ; Downes, Michael ; Evans, Ronald M. ; Saltiel, Alan R. ; Tsimikas, Sotirios ; Glass, Christopher K. ; Witztum, Joseph L.

Cell metabolism, 2020-01, Vol.31 (1), p.189-206.e8 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

5
SCFAs alleviated steatosis and inflammation in mice with NASH induced by MCD
Material Type:
Artigo
Adicionar ao Meu Espaço

SCFAs alleviated steatosis and inflammation in mice with NASH induced by MCD

Deng, Mingjuan ; Qu, Fang ; Chen, Long ; Liu, Chang ; Zhang, Ming ; Ren, Fazheng ; Guo, Huiyuan ; Zhang, Hao ; Ge, Shaoyang ; Wu, Chaodong ; Zhao, Liang

Journal of endocrinology, 2020-06, Vol.245 (3), p.425-437 [Periódico revisado por pares]

England: Bioscientifica Ltd

Texto completo disponível

6
GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease
Material Type:
Artigo
Adicionar ao Meu Espaço

GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease

Loomba, Rohit ; Kayali, Zeid ; Noureddin, Mazen ; Ruane, Peter ; Lawitz, Eric J. ; Bennett, Michael ; Wang, Lulu ; Harting, Eliza ; Tarrant, Jacqueline M. ; McColgan, Bryan J. ; Chung, Chuhan ; Ray, Adrian S. ; Subramanian, G. Mani ; Myers, Robert P. ; Middleton, Michael S. ; Lai, Michelle ; Charlton, Michael ; Harrison, Stephen A.

Gastroenterology (New York, N.Y. 1943), 2018-11, Vol.155 (5), p.1463-1473.e6 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

7
The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study
Material Type:
Artigo
Adicionar ao Meu Espaço

The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study

Faghihzadeh, Forouzan ; Adibi, Payman ; Hekmatdoost, Azita

British journal of nutrition, 2015-09, Vol.114 (5), p.796-803 [Periódico revisado por pares]

Cambridge, UK: Cambridge University Press

Texto completo disponível

8
The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement
Material Type:
Artigo
Adicionar ao Meu Espaço

The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement

Athyros, Vasilios G ; Alexandrides, Theodore K ; Bilianou, Helen ; Cholongitas, Evangelos ; Doumas, Michael ; Ganotakis, Emmanuel S ; Goudevenos, John ; Elisaf, Moses S ; Germanidis, Georgios ; Giouleme, Olga ; Karagiannis, Asterios ; Karvounis, Charalambos ; Katsiki, Niki ; Kotsis, Vasilios ; Kountouras, Jannis ; Liberopoulos, Evangelos ; Pitsavos, Christos ; Polyzos, Stergios ; Rallidis, Loukianos S ; Richter, Dimitrios ; Tsapas, Apostolos G ; Tselepis, Alexandros D ; Tsioufis, Konstantinos ; Tziomalos, Konstantinos ; Tzotzas, Themistoklis ; Vasiliadis, Themistoklis G ; Vlachopoulos, Charalambos ; Mikhailidis, Dimitri P ; Mantzoros, Christos

Metabolism, clinical and experimental, 2017-06, Vol.71, p.17-32 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

9
Role of Cholesterol‐Associated Steatohepatitis in the Development of NASH
Material Type:
Artigo
Adicionar ao Meu Espaço

Role of Cholesterol‐Associated Steatohepatitis in the Development of NASH

Horn, Christian L. ; Morales, Amilcar L. ; Savard, Christopher ; Farrell, Geoffrey C ; Ioannou, George N.

Hepatology communications, 2022-01, Vol.6 (1), p.12-35 [Periódico revisado por pares]

United States: Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins

Texto completo disponível

10
A Phase 3 Trial of Resmetirom in NASH with Liver Fibrosis. Reply
Material Type:
Artigo
Adicionar ao Meu Espaço

A Phase 3 Trial of Resmetirom in NASH with Liver Fibrosis. Reply

Harrison, Stephen A ; Taub, Rebecca

The New England journal of medicine, 2024-05, Vol.390 (17), p.1632-1633 [Periódico revisado por pares]

United States

Texto completo disponível

Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (7.637)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (8.232)
  2. Newsletter Articles  (128)
  3. magazinearticle  (11)
  4. Book Chapters  (4)
  5. Anais de Congresso  (2)
  6. Reports  (1)
  7. Mais opções open sub menu

Data de Publicação 

De até
  1. Antes de1974  (86)
  2. 1974Até1985  (94)
  3. 1986Até1997  (172)
  4. 1998Até2010  (1.440)
  5. Após 2010  (6.589)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (8.243)
  2. Japonês  (1.495)
  3. Chinês  (38)
  4. Espanhol  (31)
  5. Alemão  (30)
  6. Francês  (28)
  7. Português  (28)
  8. Russo  (23)
  9. Holandês  (6)
  10. Italiano  (4)
  11. Ucraniano  (2)
  12. Norueguês  (2)
  13. Coreano  (2)
  14. Hebraico  (1)
  15. Dinamarquês  (1)
  16. Turco  (1)
  17. Eslovaco  (1)
  18. Mais opções open sub menu

Buscando em bases de dados remotas. Favor aguardar.